Early research suggests that CRISPR gene-editing technology may some day lead to dramatic relief for…
View More CRISPR therapy fights rare disease where protein clogs organs
Home »
ERS Genomics and genOway enter CRISPR/Cas9 agreement
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual…
View More ERS Genomics and genOway enter CRISPR/Cas9 agreement
New, efficient method facilitates antibody development
In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now,…
View More New, efficient method facilitates antibody development
Doctors use CRISPR for the first time to edit blindness gene
US doctors use CRISPR gene editing tool INSIDE a person’s body to treat a rare…
View More Doctors use CRISPR for the first time to edit blindness gene
Scientists report CRISPR restores effectiveness of lung cancer treatment
The CRISPR-Cas9 gene editing system may be able to restore the effectiveness of first-line chemotherapies…
View More Scientists report CRISPR restores effectiveness of lung cancer treatment